🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
NATCO Pharma Limited (BOM:524816)
India flag India · Delayed Price · Currency is INR
817.00
-4.50 (-0.55%)
At close: Nov 20, 2026

NATCO Pharma Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
30,88940,78344,29539,98827,07119,448
Other Revenue
353524321414
30,92440,81844,31940,02027,08519,462
Revenue Growth
-29.56%-7.90%10.74%47.76%39.17%-5.34%
Cost of Revenue
6,6297,3507,2747,4876,5445,845
Gross Profit
24,29533,46837,04532,53320,54113,617
Selling, General & Admin
7,0556,9195,9915,3094,6254,806
Other Operating Expenses
9,63611,8879,0299,5996,0725,952
Operating Expenses
18,63120,88317,38316,82712,44312,383
Operating Income
5,66412,58519,66215,7068,0981,234
Interest Expense
-391-248-164-120-148-132
Interest & Investment Income
2,3192,3191,9051,013513392
Earnings From Equity Investments
1,601466----
Currency Exchange Gain (Loss)
391391198103214103
Other Non Operating Income (Expenses)
-4178726514130-3
EBT Excluding Unusual Items
9,16715,60021,86616,7168,8071,594
Merger & Restructuring Charges
-----291-11
Gain (Loss) on Sale of Investments
242414-7-5212
Gain (Loss) on Sale of Assets
-251-251901-17178427
Asset Writedown
---30--23-
Pretax Income
8,94115,37422,91416,7358,6192,022
Income Tax Expense
6471,1894,0802,8521,466322
Earnings From Continuing Operations
8,29414,18518,83413,8837,1531,700
Net Income to Company
8,29414,18518,83413,8837,1531,700
Minority Interest in Earnings
-9-20---
Net Income
8,28514,18518,85413,8837,1531,700
Net Income to Common
8,28514,18518,85413,8837,1531,700
Net Income Growth
-46.16%-24.76%35.81%94.09%320.76%-61.44%
Shares Outstanding (Basic)
179179179179183182
Shares Outstanding (Diluted)
179179179179183182
Shares Change
-0.00%--0.21%-1.67%0.08%-0.04%
EPS (Basic)
46.2679.20105.2677.3439.189.32
EPS (Diluted)
46.2679.20105.2677.3439.189.32
EPS Growth
-46.15%-24.76%36.10%97.40%320.39%-61.42%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
2,32113,80012,9578,7227,028-1,863
Free Cash Flow Per Share
12.9677.0572.3448.5938.50-10.21
Dividend Per Share
4.2505.0006.0009.5005.5004.500
Dividend Growth
-15.00%-16.67%-36.84%72.73%22.22%-14.29%
Gross Margin
78.56%81.99%83.59%81.29%75.84%69.97%
Operating Margin
18.32%30.83%44.37%39.25%29.90%6.34%
Profit Margin
26.79%34.75%42.54%34.69%26.41%8.73%
Free Cash Flow Margin
7.51%33.81%29.24%21.79%25.95%-9.57%
EBITDA
7,50514,56321,44217,5069,6692,600
EBITDA Margin
24.27%35.68%48.38%43.74%35.70%13.36%
D&A For EBITDA
1,8411,9781,7801,8001,5711,366
EBIT
5,66412,58519,66215,7068,0981,234
EBIT Margin
18.32%30.83%44.37%39.25%29.90%6.34%
Effective Tax Rate
7.24%7.73%17.81%17.04%17.01%15.93%
Revenue as Reported
33,36143,75947,84041,26928,11720,438
Advertising Expenses
-----326